STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
CPIX CUMBERLAND PHARMACEUTICALS INCORPORATED StockScouter® Report
6
StockScouter® Score
CUMBERLAND PHARMACEUTICALS INCORPORATED, a micro cap value company in the healthcare sector, is expected to slightly underperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The enterprise value-to-sales ratio is lower than the average for comparably-sized companies in the StockScouter universe. Positive
- The multi-period measure of relative price change and consistency is above average. Positive/Neutral
Concerns
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
F
C
C
B